Clinical trials: Adjuvant Treatment
Breast Cancer, Adjuvant Treatment
Impact of Oncotype DX® on Treatment Recommendation and Its Economic Evaluation Under the Brazilian Society Perspective
155 Pérola Byington Hospital patients presenting early stage luminal BC were submitted to Oncotype Dx® evaluation. Changes in treatment recommendations and costs were obtained from Pérola Byington Hospital.
- Trial name
- NCT05100277
- Testing
- Oncotype DX® Assay, Cost
- Where
- Brazil
- Volunteers
- 155 people
- Sponsor
- Hospital Perola Byington
ESCC, Adjuvant Treatment
Pembrolizumab in Post Radical Operation ESCC Patients With Lymph Node Positive ( KEYSTONE-004 )
The purpose of this study is to observe and evaluate the efficacy and safety of postoperative adjuvant treatment of pembrolizumab in patients with thoracic esophageal squamous cell carcinoma （ESCC） who have not received…
- Conditions
- ESCC, Adjuvant Treatment, Lymph Node Positive, Pembrolizumab
- Trial name
- NCT04863079
- Testing
- Pembrolizumab Injection [Keytruda]
- Where
- China
- Volunteers
- 82 people
- Sponsor
- Tianjin Medical University Cancer Institute and Hospital
Chemotherapy, Adjuvant, Lung Adenocarcinoma, Stage I
Surgery With or Without Chemotherapy for Stage I NSCLC With Micropapillary Component ≥ 20%
Randomized phase II trial aims to compare surgery with or without adjuvant chemotherapy in treating patients who are pathologically diagnosed as stage I lung adenocarcinoma with micropapillary component no less than 20%.
- Conditions
- Chemotherapy, Adjuvant, Lung Adenocarcinoma, Stage I, Treatment, Histological Type of Neoplasm
- Trial name
- NCT03351842
- Testing
- cis Platinum/Carboplatin, Pemetrexed Disodium, Undergo surgery
- Where
- China
- Volunteers
- 460 people
- Sponsor
- Shanghai Pulmonary Hospital, Shanghai, China
is to Identify Biomarkers That Could Predict the Efficacy of an Adjuvant Letrozol Treatment in Postmenopausal Breast Cancer Patients.
Evaluation of Predictive Factors Regarding the Effectivity of Aromatase Inhibitor Therapy (PreFace)
Aromatase inhibitors have shown a superior efficacy compared to tamoxifen in the treatment of hormonal receptor positive breast cancer in postmenopausal patients.
- Trial name
- PreFace (NCT01908556)
- Testing
- Letrozole
- Where
- Germany
- Volunteers
- 3,545 people
- Sponsor
- Institut fuer Frauengesundheit
Fatigue After Adjuvant Breast Cancer Treatment
An Intervention to Decrease Fatigue Among Breast Cancer Survivors
This research project is being done to design and then test whether a 10 week program can help reduce the symptoms of being tired and fatigued among women who have had breast cancer.
- Trial name
- NCT00273208
- Testing
- 10 week behavioral intervention program
- Where
- United States
- Volunteers
- 25 people
- Sponsor
- Mercy Medical Center